|
|
||||||||
Gastroenterology Research Unit, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109
CCKA receptors are present on
vagal afferent fibers. The objectives of this study were to identify
the presence of high- and low-affinity CCKA receptors on
nodose ganglia and to characterize the intracellular calcium signal
transduction activated by CCK. Stimulation of acutely isolated nodose
ganglion cells from rats with 1 nM CCK-8 primarily evoked a
Ca2+ transient followed by a sustained Ca2+
plateau (45% of cells responded), whereas 10 pM CCK-8 evoked Ca2+ oscillations (37% of cells responded). CCK-OPE, a
high-affinity agonist and low-affinity antagonist of CCKA
receptors, primarily elicited Ca2+ oscillations (29% of
cells responded). CCK-OPE inhibited the Ca2+ transient
induced by 1 nM CCK-8 but not by carbachol and high K+.
This result suggests the presence of high- and low-affinity states of
CCKA receptors on nodose ganglia. We further demonstrated that nicardipine (10 µM) but not
-conotoxins GVIA and MVIIC
(10-100 nM) abolished Ca2+ signaling induced by CCK-8,
indicating that an L-type voltage-dependent Ca2+ channel
and not an N- or Q-type Ca2+ channel is coupled to
CCKA receptors. In a separate study, we showed that the G
protein activator NaF (10 mM) elicited a Ca2+ transient and
inhibited CCK-8-evoked Ca2+ signaling, indicative of G
protein(s) involvement in CCKA receptor activity. The
Gq protein antagonist Gp antagonist-2A (10 µM) also abolished the action of CCK-8. This study indicates that
CCKA receptors exist in both high- and low-affinity states
in the nodose ganglia. Activation of high-affinity CCKA
receptors elicits Ca2+ oscillations, whereas stimulation of
low-affinity CCKA receptors evokes a sustained
Ca2+ plateau. These Ca2+-signaling modes are
mediated through the L-type Ca2+ channel and involve the
participation of Gq protein.
cholecystokinin; cholecystokinin A receptors; Ca2+ signaling
This article has been cited by other articles:
![]() |
B. J. Wang and Z. J. Cui How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R666 - R678. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Appleyard, T. W. Bailey, M. W. Doyle, Y.-H. Jin, J. L. Smart, M. J. Low, and M. C. Andresen Proopiomelanocortin Neurons in Nucleus Tractus Solitarius Are Activated by Visceral Afferents: Regulation by Cholecystokinin and Opioids J. Neurosci., April 6, 2005; 25(14): 3578 - 3585. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, X. Y. Wu, and C. Owyang Serotonin and cholecystokinin synergistically stimulate rat vagal primary afferent neurones J. Physiol., September 1, 2004; 559(2): 651 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Simasko, J. Wiens, A. Karpiel, M. Covasa, and R. C. Ritter Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1303 - R1313. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |